{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:52:06Z","timestamp":1791935526796,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005609","name":"University of Turku","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005609","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute for Health and Welfare"},{"DOI":"10.13039\/501100002341","name":"The Academy of Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In Finland, the routine surveillance of Lyme borreliosis (LB) is laboratory-based. In addition, we have well established national health care registers where countrywide data from patient visits in public health care units are collected. In our previous study based on these registers, we reported an increasing incidence of both microbiologically confirmed and clinically diagnosed LB cases in Finland during the past years. Here, we evaluated our register data, refined LB incidence estimates provided in our previous study, and evaluated treatment practices considering LB in the primary health care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Three national health care registers were used. The Register for Primary Health Care Visits (Avohilmo) and the National Hospital Discharge Register (Hilmo) collect physician-recorded data from the outpatient and inpatient health care visits, respectively, whereas the National Infectious Diseases Register (NIDR) represents positive findings in LB diagnostics notified electronically by microbiological laboratories. We used a personal identification number in register-linkage to identify LB cases on an individual level in the study year 2014. In addition, antibiotic purchase data was retrieved from the Finnish Social Insurance Institution in order to evaluate the LB treatment practices in the primary health care in Finland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Avohilmo was found to be useful in monitoring clinically diagnosed LB (i.e. erythema migrans (EM) infections), whereas Hilmo did not add much value next to existing laboratory-based surveillance of disseminated LB. However, Hilmo gave valuable information about uncertainties related to physician-based surveillance of disseminated LB and the total annual number of EM infections in our country. Antibiotic purchases associated with the LB-related outpatient visits in the primary health care indicated a good compliance with the recommended treatment guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Avohilmo and laboratory-based NIDR together are useful in monitoring LB incidence in Finland. A good compliance was observed with the recommended treatment guidelines of clinically diagnosed LB in the primary health care. In 2018, Avohilmo was introduced in the routine surveillance of LB in Finland next to laboratory-based surveillance of disseminated LB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05555-w","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T19:09:00Z","timestamp":1604948940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Lyme borreliosis in Finland: a register-based linkage study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5094-2384","authenticated-orcid":false,"given":"Eeva","family":"Feuth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Virtanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Helve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Hyt\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Sane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"issue":"9814","key":"5555_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","volume":"379","author":"G Stanek","year":"2012","unstructured":"Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379(9814):461\u201373.","journal-title":"Lancet."},{"issue":"1","key":"5555_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","volume":"17","author":"G Stanek","year":"2011","unstructured":"Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011;17(1):69\u201379.","journal-title":"Clin Microbiol Infect"},{"issue":"18","key":"5555_CR3","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1056\/NEJMcp1314325","volume":"370","author":"ED Shapiro","year":"2014","unstructured":"Shapiro ED. Clinical practice. Lyme disease. N Engl J Med. 2014;370(18):1724\u201331.","journal-title":"N Engl J Med"},{"issue":"2","key":"5555_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.idc.2015.02.010","volume":"29","author":"PS Mead","year":"2015","unstructured":"Mead PS. Epidemiology of Lyme disease. Infect Dis Clin N Am. 2015;29(2):187\u2013210.","journal-title":"Infect Dis Clin N Am"},{"key":"5555_CR5","unstructured":"Sykes RA, Makiello P. An estimate of Lyme borreliosis incidence in Western Europe. J Public Health. 2017;39(1):74\u201381."},{"issue":"7","key":"5555_CR6","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s10096-006-0167-2","volume":"25","author":"L Bennet","year":"2006","unstructured":"Bennet L, Halling A, Berglund J. Increased incidence of Lyme borreliosis in southern Sweden following mild winters and during warm, humid summers. Eur J Clin Microbiol Infect Dis. 2006;25(7):426\u201332.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5555_CR7","doi-asserted-by":"crossref","unstructured":"Smith R, Takkinen J. Lyme borreliosis: Europe-wide coordinated surveillance and action needed? Euro Surveill 2006;11(6):E060622.1.","DOI":"10.2807\/esw.11.25.02977-en"},{"key":"5555_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000213069","volume":"37","author":"Z Hub\u00e1lek","year":"2009","unstructured":"Hub\u00e1lek Z. Epidemiology of Lyme borreliosis. Curr Probl Dermatol. 2009;37:31\u201350.","journal-title":"Curr Probl Dermatol"},{"key":"5555_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13071-015-0777-6","volume":"8","author":"A Hofhuis","year":"2015","unstructured":"Hofhuis A, Harms M, Bennema S, van den Wijngaard CC, van Pelt W. Physician reported incidence of early and late Lyme borreliosis. Parasit Vectors. 2015;8:161.","journal-title":"Parasit Vectors"},{"issue":"4","key":"5555_CR10","first-page":"ix-x","volume":"35","author":"ES Theel","year":"2015","unstructured":"Theel ES. Tickborne Borrelia Infections: Beyond Just Lyme Disease. Clin Lab Med. 2015;35(4):ix-x.","journal-title":"Clin Lab Med"},{"key":"5555_CR11","volume-title":"Lyme borreliosis in Europe: influences of climate and climate change, epidemiology, ecology and adaptation measures","author":"E Lindgren","year":"2006","unstructured":"Lindgren E, Jaenson TG, Menne B. Lyme borreliosis in Europe: influences of climate and climate change, epidemiology, ecology and adaptation measures. WHO Regional Office for Europe: Copenhagen; 2006."},{"key":"5555_CR12","doi-asserted-by":"crossref","unstructured":"Dessau RB, Espenhain L, M\u00f8lbak K, Krause TG, Voldstedlund M. Improving national surveillance of Lyme neuroborreliosis in Denmark through electronic reporting of specific antibody index testing from 2010 to 2012. Euro Surveill. 2015;20(28):21184.","DOI":"10.2807\/1560-7917.ES2015.20.28.21184"},{"key":"5555_CR13","doi-asserted-by":"crossref","unstructured":"Dahl V, Wisell KT, Giske CG, Tegnell A, Wallensten A. Lyme neuroborreliosis epidemiology in Sweden 2010 to 2014: clinical microbiology laboratories are a better data source than the hospital discharge diagnosis register. Euro Surveill. 2019;24(20):1800453.","DOI":"10.2807\/1560-7917.ES.2019.24.20.1800453"},{"issue":"3","key":"5555_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ttbdis.2013.10.010","volume":"5","author":"H Wilking","year":"2014","unstructured":"Wilking H, Stark K. Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009-2012. Ticks Tick Borne Dis. 2014;5(3):219\u201324.","journal-title":"Ticks Tick Borne Dis"},{"issue":"2","key":"5555_CR15","first-page":"271","volume":"19","author":"J Chmielewska-Badora","year":"2012","unstructured":"Chmielewska-Badora J, Moniuszko A, \u017bukiewicz-Sobczak W, Zwoli\u0144ski J, Pi\u0105tek J, Pancewicz S. Serological survey in persons occupationally exposed to tick-borne pathogens in cases of co-infections with Borrelia burgdorferi, Anaplasma phagocytophilum, Bartonella spp. and Babesia microti. Ann Agric Environ Med. 2012;19(2):271\u20134.","journal-title":"Ann Agric Environ Med"},{"key":"5555_CR16","doi-asserted-by":"crossref","unstructured":"Vandenesch A, Turbelin C, Couturier E, Arena C, Jaulhac B, Ferquel E, et al. Incidence and hospitalisation rates of Lyme borreliosis, France, 2004 to 2012. Euro Surveill. 2014;19(34):20883.","DOI":"10.2807\/1560-7917.ES2014.19.34.20883"},{"issue":"8","key":"5555_CR17","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3201\/eid2308.161273","volume":"23","author":"E Sajanti","year":"2017","unstructured":"Sajanti E, Virtanen M, Helve O, Kuusi M, Lyytik\u00e4inen O, Hyt\u00f6nen J, et al. Lyme Borreliosis in Finland, 1995-2014. Emerg Infect Dis. 2017;23(8):1282\u20138.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"5555_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, S\u00f8rensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106(2):86\u201394.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"5555_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ttbdis.2016.06.006","volume":"8","author":"KE Eliassen","year":"2017","unstructured":"Eliassen KE, Berild D, Reiso H, Grude N, Christophersen KS, Finckenhagen C, et al. Incidence and antibiotic treatment of erythema migrans in Norway 2005-2009. Ticks Tick Borne Dis. 2017;8(1):1\u20138.","journal-title":"Ticks Tick Borne Dis."},{"key":"5555_CR20","doi-asserted-by":"crossref","unstructured":"Van den Wijngaard CC, Hofhuis A, Sim\u00f5es M, Rood E, van Pelt W, Zeller H, et al. Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area. Euro Surveill. 2017;22(27):30569.","DOI":"10.2807\/1560-7917.ES.2017.22.27.30569"},{"issue":"6080","key":"5555_CR21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1126\/science.1215735","volume":"336","author":"E Lindgren","year":"2012","unstructured":"Lindgren E, Andersson Y, Suk JE, Sudre B, Semenza JC. Public health. Monitoring EU emerging infectious disease risk due to climate change. Science. 2012;336(6080):418\u20139.","journal-title":"Science."},{"issue":"5","key":"5555_CR22","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1017\/S0950268805004413","volume":"133","author":"L Letrilliart","year":"2005","unstructured":"Letrilliart L, Ragon B, Hanslik T, Flahault A. Lyme disease in France: a primary care-based prospective study. Epidemiol Infect. 2005;133(5):935\u201342.","journal-title":"Epidemiol Infect"},{"issue":"3","key":"5555_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/03009740801978897","volume":"37","author":"J Hyt\u00f6nen","year":"2008","unstructured":"Hyt\u00f6nen J, Hartiala P, Oksi J, Viljanen MK. Borreliosis: recent research, diagnosis, and management. Scand J Rheumatol. 2008;37(3):161\u201372.","journal-title":"Scand J Rheumatol"},{"key":"5555_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaut.2014.09.004","volume":"57","author":"AT Borchers","year":"2015","unstructured":"Borchers AT, Keen CL, Huntley AC, Gershwin ME. Lyme disease: a rigorous review of diagnostic criteria and treatment. J Autoimmun. 2015;57:82\u2013115.","journal-title":"J Autoimmun"},{"key":"5555_CR25","unstructured":"Borrelioosin seuranta Suomessa. https:\/\/thl.fi\/fi\/web\/infektiotaudit\/taudit-ja-mikrobit\/bakteeritaudit\/borrelia\/borrelioosin-seuranta?p_p_id=56_INSTANCE_dBI4l8nyV0vb&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&p_p_col_id=column-2-2-1&p_p_col_count=1. Accessed 9 Oct 2020."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05555-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05555-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05555-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T07:26:05Z","timestamp":1604993165000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05555-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5555"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05555-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.17646\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17646\/v2","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"assertion":[{"value":"13 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authorization for register-linkage was obtained from the standing committee for register linkage studies at the NIHW (permission number THL\/604\/6.02.00\/2016). The data used in this study was anonymised before the analyses. Further ethics statement was not needed based on the internal regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"819"}}